Cambio a ranibizumab en edema macular diabético refractario al tratamiento con bevacizumab.

Citation data:

Archivos de la Sociedad Espanola de Oftalmologia, ISSN: 1989-7286, Vol: 93, Issue: 11, Page: 523-529

Publication Year:
2018
Captures 0
Readers 0
Social Media 1
Tweets 1
PMID:
29861068
DOI:
10.1016/j.oftal.2018.04.001
Author(s):
M. Ashraf; A. A. Souka; H. el Kayal; M. Daich Varela; P. G. Schlottmann
Publisher(s):
Elsevier BV
Tags:
Medicine
Most Recent Tweet View All Tweets
article description
To determine the efficacy of switching to ranibizumab in patients with diabetic macular oedema refractory to treatment with bevacizumab, and to evaluate the outcomes when switching back to bevacizumab.